CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,567,247
- in 1 filing
Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Grant or award · Employee Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Returned to the company · Employee Stock Option (Right to Buy) | −90,000 | 0 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Returned to the company · Employee Stock Option (Right to Buy) | −135,000 | 0 | ||
| 2025-05-13 | Manji Husseini Director | Grant or award · Stock Option (right to buy) | +15,287 | 15,287 | ||
| 2025-05-13 | Cox Christopher Nixon Director | Grant or award · Stock Option (right to buy) | +15,287 | 15,287 | ||
| 2025-05-13 | Dreyfus Andrew Director | Grant or award · Stock Option (right to buy) | +15,287 | 15,287 | ||
| 2025-05-13 | York Gwill Director | Grant or award · Stock Option (right to buy) | +15,287 | 15,287 | ||
| 2025-02-05 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-02-05 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2025-02-05 | Savitz Adam CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +76,000 | 76,000 | ||
| 2025-02-05 | Etkin Amit PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +215,000 | 215,000 | ||
| 2025-01-02 | York Gwill Director | Grant or award · Stock Option (right to buy) | +19,558 | $3.17 | $62K | 19,558 |
| 2025-01-02 | Manji Husseini Director | Grant or award · Stock Option (right to buy) | +14,195 | $3.17 | $45K | 14,195 |
| 2025-01-02 | Cox Christopher Nixon Director | Grant or award · Stock Option (right to buy) | +25,236 | $3.17 | $80K | 25,236 |
| 2024-07-10 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | +2,931 | $13.22 | $39K | 39,851 |
| 2024-07-09 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | +10,681 | $12.53 | $134K | 35,532 |
| 2024-07-09 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | +1,388 | $13.15 | $18K | 36,920 |
| 2024-05-20 | Hanley Jr. Michael Conick Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +188,000 | 188,000 | ||
| 2024-03-28 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Purchase | +1,600 | $15.80 | $25K | 22,316 |
Page 4 of 7 · 125 trades